Click it and Unblock the Notifications
For Quick Alerts
For Daily Alerts
Just In
Don't Miss
-
Dharamshala Stadium Embraces Cutting-Edge SISGrass Hybrid Pitch Technology To Revolutionise Indian Cricket -
How To Choose Earrings For Your Outfits, 6 Tips To Ace The Art Of Jewellery Selection -
Penny Stock Below Rs 50 Announces Major Update On 6:11 Bonus Shares; Bet? -
From Coconut Breaking on Head to Men Dressing as Women: 12 Unique Indian Rituals Explored -
Thug Life: Rumours Suggest Dulquer Salmaan Is Back In Kamal Haasan's Film; Sources Say Otherwise; Details HERE -
ASUS Zenbook DUO 2024 Launched in India – Check Price, Specs, Where to Buy -
Renault Duster And Nissan Models To Feature Turbo-Petrol Engines: Hybrid In The Makes? -
TN MRB Assistant Surgeon Recruitment 2024; 2553 Vacancies, Application Procedure Selection Details and more
Covid-19: Beginning 2021, India to produce 100 million doses of Russia’s Sputnik V vaccine
New Delhi, Nov 27: Russian Direct Investment Fund (RDIF) and pharma firm Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against COVID-19, Russia's sovereign wealth fund said in a statement.
The parties intend to start the production of Sputnik V in the beginning of 2021, it added.
Recommended Video
Oxford
Astra
Zeneca's
vaccine
error
|
What
happens
to
India
trials?
|
Oneindia
News
Currently Phase III clinical trials are approved and are ongoing in Belarus, the UAE, Venezuela and other countries. Phase II-III trials are taking place in India, RDIF said.
Comments
